Webcast: Update EU Pharma Legislation

Morgan, Lewis & Bockius LLP, Munich, GERMANY

Life Sciences Regulatory Partner;
Alexander Meier is a German trained lawyer with more than 25 years of relevant professional experience, specialised in European and German pharmaceutical law concerning research, development, authorisation and commercialisation of medicinal products and medical devices.
He started his professional career in 2000 in Munich (DE) and worked both as outside counsel for various law firms as well as for over 13 years as an in-house lawyer, including for Novartis and Moderna. In February 2026 Alexander Meier joined the law firm Morgan, Lewis & Bockius as Partner in their Munich office.
Alexander Meier is the author of numerous publications, a regular speaker at international conferences, and lecturer at the CEIPI of the University of Strasbourg (FR).

Pharma Deutschland e.V., Berlin, GERMANY

Anna Wehage is currently working as a Senior Advisor for National and European Health Policy at Pharma Deutschland e.V. With over seven years of experience in the pharmaceutical industry and another seven years in association work, she combines hands-on expertise in pharmaceutical manufacturing and quality processes with a strong background in health policy and regulatory affairs at both national and European levels.
Previously, she served as Head of Quality Department in the pharmaceutical industry, where she gained extensive experience in regulatory processes within pharmaceutical manufacturing and quality control. Anna Wehage holds a Master's degree in Drug Regulatory Affairs from the University of Bonn and a Diploma in Biology from the Technical University of Kaiserslautern.

CENCORA
PharmaLex, Mannheim, GERMANY

Dr. Angela Vogt-Eisele has over 15 years of experience in the pharmaceutical industry supporting nonclinical and clinical development programs for small molecule drugs, advanced therapy medicinal products, biologics, food supplements and medical devices. One of her central areas of expertise lies in the field of environmental risk assessments (Europe, USA and world-wide).
Prior to joining Cencora PharmaLex, Angela worked at Sygnis Bioscience GmbH as head of the in vitro department (2007-2012) being responsible for research and development in the area of stroke and dementia.
Dr. Angela Vogt-Eisele holds a Diploma in Biology (University of Tübingen, focus: Molecular Genetics, Biochemistry, Immunology) and a doctoral degree (Dr. rer.nat, Max-Planck-Institute for Polymer Research and University of Mainz).

Federal Association of the Pharmaceutical Industry (BPI) e.V., Berlin, GERMANY

Member of the Management Board (Medical and Scientific Affairs),
Head of the Drug Authorisation Department;
Since March 2006, Britta Ginnow has been working as the Head of the Drug Authorisation Department at the Federal Association of the Pharmaceutical Industry (BPI) e.V. Her main responsibilities include national and European authorisation and maintenance procedures, which also encompass electronic submissions. Further focal points are regulations concerning patient and product information leaflets, the use of digital media for these purposes, the classification of medicinal products, and environmental risk assessments in the context of marketing authorisations.
Ms Ginnow holds a degree in Food Chemistry and began her career in the pharmaceutical industry in 1998 in the fields of product development and authorisation of medicinal products at a contract manufacturer for soft gelatine capsules.
From 2001, she worked in Regulatory Affairs at two other companies, managing the authorisations for products marketed nationally and internationally. She completed a part-time Masters degree in Drug Regulatory Affairs.